Oleanolic acid injection - Biostar

Drug Profile

Oleanolic acid injection - Biostar

Latest Information Update: 07 Oct 2014

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator BioStar Pharmaceuticals
  • Class Antirheumatics; Nonsteroidal anti-inflammatories; Oleanolic acids; Triterpenoid sapogenins
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Phase Unknown Hepatitis B; Liver cancer

Most Recent Events

  • 18 Sep 2014 Investigation in Hepatitis B in China (Parenteral)
  • 06 Mar 2014 Investigation in Liver cancer in China (Injection)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top